Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 529-534

  Zu, Yukun ^a   Ban, Jinbao ^a   Xia, Zhenxiong ^a   Wang, Jianing ^a   Cai, Yixin ^a   Ping, Wei ^a   Sun, Wei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Lung cancer; Microrna 335; Risk; Single nucleotide polymorphism

Indexed keywords

BACULOVIRAL IAP REPEAT CONTAINING 5 PROTEIN; CYSTEINE; MICRORNA; MICRORNA 335; ONCOPROTEIN; THREONINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; BINDING SITE; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CANCER TISSUE; CHINESE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE REPLICATION; GENE TARGETING; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REPORTER GENE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BINDING SITES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84872330883     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.001     Document Type: Article

References (25)

1. Yang L., Parkin D.M., Li L.D., et al. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br. J. Cancer 2004, 90:2157-2166.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J. Clin. 2008, 58(2008):71-96.
3. Bosetti C., Boffetta P., La Vecchia C. Occupational exposures to polycyclic aromatic hydrocarbons, and respiratory and urinary tract cancers: a quantitative review to 2005. Ann. Oncol. 2007, 18:431-446.
4. Shields P.G., Harris C.C. Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J. Clin. Oncol. 2000, 18:2309-2315.
5. Herbst R.S., Heymach J.V., Lippman S.M. Lung cancer. N. Engl. J. Med. 2008, 359:1367-1380.
6. Berezikov E., Guryev V., van de Belt J., et al. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
7. Zamore P.D., Haley B. Ribo-gnome: the big world of small RNAs. Science 2005, 309:1519-1524.
8. Carthew R.W. Gene regulation by microRNAs. Curr. Opin. Genetics Dev. 2006, 16:203-208.
9. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
10. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 2010, 10:389-402.
11. Liu Z., Wei S., Ma H., et al. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 2011, 32:1668-1674.
12. S. Zhang, H. Chen, X. Zhao, et al., REV3L 3' UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility, Oncogene (2012). Accessed on Oct 17, 2012. doi:10.1038/onc.2012.32.
13. Teo M.T., Landi D., Taylor C.F., et al. The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis 2012, 33:581-586.
14. Sah N.K., Khan Z., Khan G.J., et al. Structural, functional and therapeutic biology of survivin. Cancer Lett. 2006, 244:164-171.
15. Tamm I., Wang Y., Sausville E., et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 1998, 58:5315-5320.
16. Xiang R., Mizutani N., Luo Y., et al. A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication. Cancer Res. 2005, 65:553-561.
17. K. Wang, J. Li, H. Guo, et al., MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis, Carcinogenesis (2012). Accessed on Oct 17, 2012. doi:10.1093/carcin/bgs259.
18. Slack F.J., Weidhaas J.B. MicroRNA in cancer prognosis. N. Engl. J. Med. 2008, 359:2720-2722.
19. Lang I., Hoffmann C., Olip H., et al. Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif. 2001, 34:143-155.
20. Weston G., Trajstman A.C., Gargett C.E., et al. Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol. Hum. Reprod. 2003, 9:541-549.
21. Sung H., Jeon S., Lee K.M., et al. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival. BMC Cancer 2012, 12:195.
22. Y. Zhou, J. Wang, X. Lu, et al., Evaluation of Six SNPs of MicroRNA Machinery Genes and Risk of Schizophrenia, J Mol Neurosci (2012). Accessed on Oct 17, 2012. doi:10.1007/s12031-012-9887-1.
23. He Y., Zhou Y., Xi Q., et al. Genetic variations in microRNA processing genes are associated with susceptibility in depression. DNA Cell Biol. 2012, 31:1499-1506.
24. Chen K., Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat. Genet. 2006, 38:1452-1456.
25. Saunders M.A., Liang H., Li W.H. Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. USA 2007, 104:3300-3305.